2018
DOI: 10.1016/j.virusres.2017.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies

Abstract: HIV/AIDS has become a worldwide pandemic. Before an effective HIV-1 vaccine eliciting broadly neutralizing monoclonal antibodies (bnmAbs) is fully developed, passive immunization for prevention and treatment of HIV-1 infection may alleviate the burden caused by the pandemic. Among HIV-1 infected individuals, about 20% of them generated cross-reactive neutralizing antibodies two to four years after infection, the details of which could provide knowledge for effective vaccine design. Recent progress in technique… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 170 publications
0
11
0
Order By: Relevance
“…Other traditional methods of generating mAbs, such as Epstein-Barr virus-transformation and phage-display libraries, are limited by being unstable, time consuming or inefficient (14,15). With the advent of single-cell reverse transcription PCR (RT-PCR) technologies, the amplification of full-length immunoglobulin gene (Ig) fragments from single B cells by utilizing nested PCR has allowed the bypass of many of these limitations and this technology has been shown to provide a versatile tools for generation of new mAbs; this is an important advancement in mAbs production (16,17). Prior to the amplification of Ig-encoding genes, antigen-specific memory B cells must be stained with fluorescently-labelled antigen baits and then sorted.…”
Section: Introductionmentioning
confidence: 99%
“…Other traditional methods of generating mAbs, such as Epstein-Barr virus-transformation and phage-display libraries, are limited by being unstable, time consuming or inefficient (14,15). With the advent of single-cell reverse transcription PCR (RT-PCR) technologies, the amplification of full-length immunoglobulin gene (Ig) fragments from single B cells by utilizing nested PCR has allowed the bypass of many of these limitations and this technology has been shown to provide a versatile tools for generation of new mAbs; this is an important advancement in mAbs production (16,17). Prior to the amplification of Ig-encoding genes, antigen-specific memory B cells must be stained with fluorescently-labelled antigen baits and then sorted.…”
Section: Introductionmentioning
confidence: 99%
“…Classical serology approaches, based on ELISA and viral neutralization assays, offer a wealth of information but require a relatively large set of biological and viral reagents (3)(4)(5). For rational and structure-based vaccine design efforts it is also necessary to isolate specific monoclonal antibodies (mAbs) elicited by a vaccine/pathogen (6)(7)(8)(9)(10)(11), yet the isolation of antigenspecific B-cells requires fluorescently labeled probes and access to advanced cell sorting equipment (12)(13)(14). Individual monoclonal antibodies are subsequently produced and subjected to further binding, structural and functional evaluation to assess epitope specificity, affinity, and activity (i.e.…”
Section: Main Textmentioning
confidence: 99%
“…In addition to the hybridoma technique, B cell immortalization and microneutralization, [ 111 ] large‐scale screening of libraries by phage, ribosome, yeast, or bacterial display are widely applied in antibody isolation. [ 112,113,61,114 ] Using these technologies, we and others have successfully developed functional antibodies against various targets.…”
Section: Strategies Of Functional Antibody Discovery From Antibody Rementioning
confidence: 99%